NOVEL EXCIPIENT-FREE FORMULATION OF ETOPOSIDE

ERGANEO



30 Septembre 2021

Partager sur facebook Partager sur twitter Partager sur linkedin Partager sur google+

Fields

Biology / Medical

Sectors

Health

70% of drug molecules face problems of poor bioavailability and instability. Etoposide is a commonly used molecule to treat several cancers, which faces those problems and usual side effects. Nanotechnology applied to medicine can provide important progress, offently by improving bioavailability and dose optimization. Researchers propose here a new formulation of etoposide, excipient-free and based on nanocrystals, improving biodisponibility & dose efficacy. POC in vivo has been established, along with PK and tissue distribution showing improved performance compared to standard Toposar formulation.

Applications:

  • Cancers
  • Testis embryonal carcinoma
  • Acute leukemia
  • Placental choriocarcinoma
  • Small lung cancer
  • Breast and ovarian cancer

Competitive advantages:

  • Low toxicity
  • Better biodisponibility
  • Better efficiency
  • Less administration
  • Suitable for different galenic forms

Keywords: Etoposide, Cancer, Formulation, Excipient-free formulation, Biodisponibility

Download the offer Download the offer

Newsletter